Email ID
Password
Scrip   
Leo Pharma recoups psoriasis products from Warner Chilcott for $1 billion
24 September 2009
Christopher Spillane

Leo Pharma has agreed to re-acquire the US rights to its topical psoriasis treatments from Warner Chilcott for $1 billion in cash.

The Danish company is buying back the licensing rights for Taclonex (calcipotriene plus betamethasone), Taclonex Scalp, Dovonex (calcipotriol) plus...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36